Skip to content

Randomised control study using Diclofenac patch

Efficacy of Diclofenac transdermal patch versus injectable Diclofenac in post LSCS analgesia- A comparative, double blind random controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048088
Enrollment
90
Registered
2022-12-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O269- Pregnancy related conditions, unspecified

Interventions

Intervention1: Patients are divided into two randomized groups In one group transdermal diclofenac patch is applied as post operation analgesia, in another group Injectable Diclofenac is given.: All p

Sponsors

Director USM KLE IMP
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All pregnant women undergoing Lower Segment Caesarian Section in the age range of 18 to 40 years healthy normal pregnancy completed 38 weeks duration no or mild systemic diseases satisfying to American Society of Anesthesiologists Group I and II who are willing to participate are included in the study

Exclusion criteria

Exclusion criteria: Patients unsuitable for spinal anaesthesia, history of allergy to analgesic drugs, women with bowel disorders like ulcers inflammatory bowel disease ASA group III and IV and not willing to participate were excluded from the study

Design outcomes

Primary

MeasureTime frame
Visual analogue scale score No Pain Satisfactory post operation analgesiaTimepoint: at four hours after Caesarian delivery and there after interval of four hours for 48 hours

Secondary

MeasureTime frame
The first four post operation days following Caesarian delivery pain free, visual analogue score 1-3 mmTimepoint: Following caesarian delivery mothers do feel pain free at third and fourth days

Countries

India

Contacts

Public ContactDr Satish Dhamankar

USM KLE IMP

drsdhamankar@yahoo.com9448151441

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026